Patients with psoriatic arthritis who received GLP-1 receptor agonists exhibited lower risks for mortality and cardiovascular ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best NYSE stocks to buy and hold for the next decade. On October 27, ...

What are called autoimmune diseases can affect just about every part of the body – and tens of millions of people. While most ...

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Psoriatic arthritis (PsA) has been around for thousands of years. Archaeologists unearthed Egyptian mummies with signs of the disease. Back then, the treatments for swollen and painful joints and red, ...

The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to ...

GLP-1RAs were associated with lower risks for major adverse cardiac events, including heart failure, among patients with ...

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

People with psoriatic arthritis often have psoriasis. They tend to have or get a few other diseases, too. There's no clear reason why these other conditions go hand in hand, and researchers are ...

Psoriatic arthritis is an inflammatory autoimmune disease that frequently occurs in people with psoriasis, a skin condition that leads to itchy, scaly lesions, often on the knees, elbows, torso, and ...

Perimenopause was linked to higher PsA disease activity and greater tender/swollen joint counts when compared with the pre- ...